Search Results 161-170 of 18372 for crohn's disease

1. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   ... and severely active Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

2. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. ... AND active symptoms of Crohn's disease ( ...

3. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

   Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic ...

4. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

   ... inflammatory bowel disease (IBD) (Crohn's ... Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

5. Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects with Crohn's Disease and Who Participated and Successfully Completed M14-115 - Mayo Clinic

   This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.

6. A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) - Mayo Clinic

   A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) · Share ...

7. A Study to Test the Safety and Effectiveness of PF-00547659 for Patients who have Crohn's Disease - Mayo Clinic

   The purpose of this study is to assess the safety and effectiveness of PF-00547659 (experimental drug) for patients who have Crohn's disease that is clinically ...

8. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   ... and effectiveness of adalimumab in pediatric patients with moderately to severely active crohn's disease ... and stage of disease, and previous treatments ...

9. Frequent bowel movements Causes - Mayo Clinic

   Celiac disease · Crohn's disease — which causes tissues in the digestive tract to become inflamed. Ulcerative colitis — a disease that causes ulcers and ...

10. Crohn's disease - Doctors and departments - Mayo Clinic

    Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.